...
首页> 外文期刊>Journal of Medicinal Chemistry >Development and Validation of k-Nearest-Neighbor QSPR Models of Metabolic Stability of Drug Candidates
【24h】

Development and Validation of k-Nearest-Neighbor QSPR Models of Metabolic Stability of Drug Candidates

机译:候选药物代谢稳定性的k最近邻QSPR模型的开发和验证

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Computational ADME (absorption, distribution, metabolism, and excretion) models may be used early in the drug discovery process in order to flag drug candidates with potentially problematic ADME profiles. We report the development, validation, and application of quantitative structure-property relationship (QSPR) models of metabolic turnover rate for compounds in human S9 homogenate. Biological data were obtained from uniform bioassays of 631 diverse chemicals proprietary to GlaxoSmithKline (GSK). The models were built with topological molecular descriptors such as molecular connectivity indices or atom pairs using the k-nearest neighbor variable selection optimization method developed at the University of North Carolina (Zheng, W.; Tropsha, A. A novel variable selection QSAR approach based on the k-nearest neighbor principle. J. Chem. Inf. Comput. Sci., 2000, 40, 185-194). For the purpose of validation, the whole data set was divided into training and test sets. The training set QSPR models were characterized by high internal accuracy with leave-one-out cross-validated R~2 (q~2) values ranging between 0.5 and 0.6 The test set compounds were correctly classified as stable or unstable in S9 assay with an accuracy above 85%. These models were additionally validated by in silico metabolic stability screening of 107 new chemicals under development in several drug discovery programs at GSK. One representative model generated with MolConnZ descriptors predicted 40 compounds to be metabolically stable (turnover rate less than 25%), and 33 of them were indeed found to be stable experimentally. This success (83% concordance) in correctly picking chemicals that are metabolically stable in the human S9 homogenate spells a rapid, computational screen for generating components of the ADME profile in a drug discovery process.
机译:可以在药物发现过程的早期使用计算ADME(吸收,分布,代谢和排泄)模型,以便用潜在有问题的ADME配置文件标记候选药物。我们报告开发,验证和人类S9匀浆中的化合物的代谢周转率的定量结构-属性关系(QSPR)模型的应用。生物学数据是从葛兰素史克(GSK)专有的631种不同化学品的统一生物测定中获得的。使用北卡罗来纳大学(Zheng,W .; Tropsha,A.)开发的k最近邻变量选择优化方法,使用拓扑分子描述符(例如分子连通性指数或原子对)构建模型。 (J. Chem。Inf。Comput。Sci。,2000,40,185-194)。为了进行验证,将整个数据集分为训练集和测试集。训练集QSPR模型的特点是内部准确度高,交叉验证的R〜2(q〜2)值在0.5到0.6之间。测试集化合物在S9分析中被正确分类为稳定或不稳定。准确度在85%以上。这些模型还通过GSK几个药物发现计划中正在开发的107种新化学药品的计算机代谢稳定性筛选进行了验证。使用MolConnZ描述子生成的一个代表性模型预测40种化合物在代谢上是稳定的(周转率低于25%),而在实验中确实发现其中33种是稳定的。正确选择人类S9匀浆中代谢稳定的化学药品的这一成功(83%的一致性),为在药物发现过程中生成ADME配置文件成分的快速计算提供了便利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号